nodes	percent_of_prediction	percent_of_DWPC	metapath
Eprosartan—ABCC2—Mycophenolate mofetil—systemic scleroderma	0.245	0.514	CbGbCtD
Eprosartan—CYP2C9—Leflunomide—systemic scleroderma	0.133	0.28	CbGbCtD
Eprosartan—ABCC2—Methotrexate—systemic scleroderma	0.0984	0.206	CbGbCtD
Eprosartan—CYP2C9—cardial valve—systemic scleroderma	0.0404	0.419	CbGeAlD
Eprosartan—AGTR1—artery—systemic scleroderma	0.0126	0.131	CbGeAlD
Eprosartan—AGTR1—endothelium—systemic scleroderma	0.0106	0.11	CbGeAlD
Eprosartan—AGTR1—blood vessel—systemic scleroderma	0.0098	0.102	CbGeAlD
Eprosartan—AGTR1—connective tissue—systemic scleroderma	0.00502	0.0521	CbGeAlD
Eprosartan—AGTR1—smooth muscle tissue—systemic scleroderma	0.0046	0.0477	CbGeAlD
Eprosartan—Losartan—ACE—systemic scleroderma	0.00449	1	CrCbGaD
Eprosartan—AGTR1—tendon—systemic scleroderma	0.00345	0.0358	CbGeAlD
Eprosartan—AGTR1—lung—systemic scleroderma	0.00303	0.0315	CbGeAlD
Eprosartan—ABCC2—digestive system—systemic scleroderma	0.00262	0.0272	CbGeAlD
Eprosartan—ABCC2—tendon—systemic scleroderma	0.0025	0.0259	CbGeAlD
Eprosartan—CYP2C9—digestive system—systemic scleroderma	0.00175	0.0181	CbGeAlD
Eprosartan—Tension—Mycophenolate mofetil—systemic scleroderma	0.000433	0.00103	CcSEcCtD
Eprosartan—Insomnia—Leflunomide—systemic scleroderma	0.000433	0.00103	CcSEcCtD
Eprosartan—Paraesthesia—Leflunomide—systemic scleroderma	0.00043	0.00102	CcSEcCtD
Eprosartan—Chest pain—Lisinopril—systemic scleroderma	0.000429	0.00102	CcSEcCtD
Eprosartan—Arthralgia—Lisinopril—systemic scleroderma	0.000429	0.00102	CcSEcCtD
Eprosartan—Myalgia—Lisinopril—systemic scleroderma	0.000429	0.00102	CcSEcCtD
Eprosartan—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.000429	0.00102	CcSEcCtD
Eprosartan—Anxiety—Lisinopril—systemic scleroderma	0.000427	0.00101	CcSEcCtD
Eprosartan—Back pain—Mycophenolate mofetil—systemic scleroderma	0.000427	0.00101	CcSEcCtD
Eprosartan—Dyspnoea—Leflunomide—systemic scleroderma	0.000427	0.00101	CcSEcCtD
Eprosartan—Hypotension—Mycophenolic acid—systemic scleroderma	0.000427	0.00101	CcSEcCtD
Eprosartan—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000424	0.00101	CcSEcCtD
Eprosartan—Discomfort—Lisinopril—systemic scleroderma	0.000424	0.001	CcSEcCtD
Eprosartan—Dyspepsia—Leflunomide—systemic scleroderma	0.000421	0.000998	CcSEcCtD
Eprosartan—Vomiting—Mometasone—systemic scleroderma	0.00042	0.000996	CcSEcCtD
Eprosartan—Dry mouth—Lisinopril—systemic scleroderma	0.000419	0.000994	CcSEcCtD
Eprosartan—Sweating increased—Prednisone—systemic scleroderma	0.000418	0.000991	CcSEcCtD
Eprosartan—Feeling abnormal—Azathioprine—systemic scleroderma	0.000418	0.000989	CcSEcCtD
Eprosartan—Rash—Mometasone—systemic scleroderma	0.000417	0.000988	CcSEcCtD
Eprosartan—Asthenia—Captopril—systemic scleroderma	0.000417	0.000987	CcSEcCtD
Eprosartan—Dermatitis—Mometasone—systemic scleroderma	0.000416	0.000987	CcSEcCtD
Eprosartan—Decreased appetite—Leflunomide—systemic scleroderma	0.000416	0.000986	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000416	0.000985	CcSEcCtD
Eprosartan—Osteoarthritis—Methotrexate—systemic scleroderma	0.000415	0.000984	CcSEcCtD
Eprosartan—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000414	0.000982	CcSEcCtD
Eprosartan—Headache—Mometasone—systemic scleroderma	0.000414	0.000981	CcSEcCtD
Eprosartan—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000414	0.00098	CcSEcCtD
Eprosartan—Insomnia—Mycophenolic acid—systemic scleroderma	0.000413	0.000978	CcSEcCtD
Eprosartan—Fatigue—Leflunomide—systemic scleroderma	0.000413	0.000978	CcSEcCtD
Eprosartan—Pruritus—Captopril—systemic scleroderma	0.000411	0.000973	CcSEcCtD
Eprosartan—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00041	0.000971	CcSEcCtD
Eprosartan—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.00041	0.00097	CcSEcCtD
Eprosartan—Pain—Leflunomide—systemic scleroderma	0.000409	0.00097	CcSEcCtD
Eprosartan—Constipation—Leflunomide—systemic scleroderma	0.000409	0.00097	CcSEcCtD
Eprosartan—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000407	0.000964	CcSEcCtD
Eprosartan—Somnolence—Mycophenolic acid—systemic scleroderma	0.000406	0.000962	CcSEcCtD
Eprosartan—Shock—Lisinopril—systemic scleroderma	0.000404	0.000958	CcSEcCtD
Eprosartan—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000403	0.000956	CcSEcCtD
Eprosartan—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000403	0.000954	CcSEcCtD
Eprosartan—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000402	0.000952	CcSEcCtD
Eprosartan—Tachycardia—Lisinopril—systemic scleroderma	0.000401	0.000951	CcSEcCtD
Eprosartan—Abdominal pain—Azathioprine—systemic scleroderma	0.000401	0.000949	CcSEcCtD
Eprosartan—Body temperature increased—Azathioprine—systemic scleroderma	0.000401	0.000949	CcSEcCtD
Eprosartan—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000398	0.000943	CcSEcCtD
Eprosartan—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000397	0.000942	CcSEcCtD
Eprosartan—Diarrhoea—Captopril—systemic scleroderma	0.000397	0.000941	CcSEcCtD
Eprosartan—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000397	0.00094	CcSEcCtD
Eprosartan—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000397	0.00094	CcSEcCtD
Eprosartan—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000396	0.000938	CcSEcCtD
Eprosartan—Feeling abnormal—Leflunomide—systemic scleroderma	0.000394	0.000934	CcSEcCtD
Eprosartan—Fatigue—Mycophenolic acid—systemic scleroderma	0.000394	0.000933	CcSEcCtD
Eprosartan—Nausea—Mometasone—systemic scleroderma	0.000393	0.00093	CcSEcCtD
Eprosartan—Anorexia—Lisinopril—systemic scleroderma	0.000392	0.000929	CcSEcCtD
Eprosartan—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000391	0.000927	CcSEcCtD
Eprosartan—Ataxia—Methotrexate—systemic scleroderma	0.00039	0.000925	CcSEcCtD
Eprosartan—Pain—Mycophenolic acid—systemic scleroderma	0.00039	0.000925	CcSEcCtD
Eprosartan—Constipation—Mycophenolic acid—systemic scleroderma	0.00039	0.000925	CcSEcCtD
Eprosartan—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00039	0.000924	CcSEcCtD
Eprosartan—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000388	0.000919	CcSEcCtD
Eprosartan—Hyperglycaemia—Prednisone—systemic scleroderma	0.000387	0.000918	CcSEcCtD
Eprosartan—Cough—Mycophenolate mofetil—systemic scleroderma	0.000385	0.000913	CcSEcCtD
Eprosartan—Hypotension—Lisinopril—systemic scleroderma	0.000384	0.00091	CcSEcCtD
Eprosartan—Dizziness—Captopril—systemic scleroderma	0.000384	0.00091	CcSEcCtD
Eprosartan—Depression—Prednisone—systemic scleroderma	0.000382	0.000905	CcSEcCtD
Eprosartan—Urticaria—Leflunomide—systemic scleroderma	0.00038	0.000901	CcSEcCtD
Eprosartan—Abdominal pain—Leflunomide—systemic scleroderma	0.000378	0.000896	CcSEcCtD
Eprosartan—Body temperature increased—Leflunomide—systemic scleroderma	0.000378	0.000896	CcSEcCtD
Eprosartan—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000376	0.000891	CcSEcCtD
Eprosartan—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000376	0.00089	CcSEcCtD
Eprosartan—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000376	0.00089	CcSEcCtD
Eprosartan—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000376	0.00089	CcSEcCtD
Eprosartan—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000375	0.000889	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000375	0.000888	CcSEcCtD
Eprosartan—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000374	0.000887	CcSEcCtD
Eprosartan—Hypersensitivity—Azathioprine—systemic scleroderma	0.000373	0.000885	CcSEcCtD
Eprosartan—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000373	0.000884	CcSEcCtD
Eprosartan—Insomnia—Lisinopril—systemic scleroderma	0.000372	0.000881	CcSEcCtD
Eprosartan—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000371	0.00088	CcSEcCtD
Eprosartan—Paraesthesia—Lisinopril—systemic scleroderma	0.000369	0.000875	CcSEcCtD
Eprosartan—Vomiting—Captopril—systemic scleroderma	0.000369	0.000875	CcSEcCtD
Eprosartan—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000368	0.000871	CcSEcCtD
Eprosartan—Dyspnoea—Lisinopril—systemic scleroderma	0.000367	0.000869	CcSEcCtD
Eprosartan—Rash—Captopril—systemic scleroderma	0.000366	0.000867	CcSEcCtD
Eprosartan—Dermatitis—Captopril—systemic scleroderma	0.000366	0.000867	CcSEcCtD
Eprosartan—Somnolence—Lisinopril—systemic scleroderma	0.000366	0.000866	CcSEcCtD
Eprosartan—Headache—Captopril—systemic scleroderma	0.000364	0.000862	CcSEcCtD
Eprosartan—Dyspepsia—Lisinopril—systemic scleroderma	0.000362	0.000858	CcSEcCtD
Eprosartan—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000361	0.000855	CcSEcCtD
Eprosartan—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000361	0.000855	CcSEcCtD
Eprosartan—Asthma—Methotrexate—systemic scleroderma	0.000359	0.00085	CcSEcCtD
Eprosartan—Decreased appetite—Lisinopril—systemic scleroderma	0.000357	0.000847	CcSEcCtD
Eprosartan—Fatigue—Lisinopril—systemic scleroderma	0.000354	0.00084	CcSEcCtD
Eprosartan—Shock—Mycophenolate mofetil—systemic scleroderma	0.000354	0.00084	CcSEcCtD
Eprosartan—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000353	0.000836	CcSEcCtD
Eprosartan—Hypersensitivity—Leflunomide—systemic scleroderma	0.000353	0.000835	CcSEcCtD
Eprosartan—Pain—Lisinopril—systemic scleroderma	0.000352	0.000833	CcSEcCtD
Eprosartan—Constipation—Lisinopril—systemic scleroderma	0.000352	0.000833	CcSEcCtD
Eprosartan—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000352	0.000833	CcSEcCtD
Eprosartan—Bradycardia—Prednisone—systemic scleroderma	0.00035	0.000829	CcSEcCtD
Eprosartan—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000348	0.000825	CcSEcCtD
Eprosartan—Diarrhoea—Azathioprine—systemic scleroderma	0.000347	0.000821	CcSEcCtD
Eprosartan—Nausea—Captopril—systemic scleroderma	0.000345	0.000817	CcSEcCtD
Eprosartan—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000343	0.000814	CcSEcCtD
Eprosartan—Asthenia—Leflunomide—systemic scleroderma	0.000343	0.000813	CcSEcCtD
Eprosartan—Feeling abnormal—Lisinopril—systemic scleroderma	0.000339	0.000803	CcSEcCtD
Eprosartan—Pruritus—Leflunomide—systemic scleroderma	0.000339	0.000802	CcSEcCtD
Eprosartan—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000337	0.000798	CcSEcCtD
Eprosartan—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000336	0.000797	CcSEcCtD
Eprosartan—Dizziness—Azathioprine—systemic scleroderma	0.000335	0.000794	CcSEcCtD
Eprosartan—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000334	0.00079	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000328	0.000778	CcSEcCtD
Eprosartan—Asthenia—Mycophenolic acid—systemic scleroderma	0.000327	0.000776	CcSEcCtD
Eprosartan—Diarrhoea—Leflunomide—systemic scleroderma	0.000327	0.000776	CcSEcCtD
Eprosartan—Urticaria—Lisinopril—systemic scleroderma	0.000327	0.000774	CcSEcCtD
Eprosartan—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000326	0.000772	CcSEcCtD
Eprosartan—Abdominal pain—Lisinopril—systemic scleroderma	0.000325	0.00077	CcSEcCtD
Eprosartan—Body temperature increased—Lisinopril—systemic scleroderma	0.000325	0.00077	CcSEcCtD
Eprosartan—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000323	0.000766	CcSEcCtD
Eprosartan—Pruritus—Mycophenolic acid—systemic scleroderma	0.000323	0.000765	CcSEcCtD
Eprosartan—Vomiting—Azathioprine—systemic scleroderma	0.000322	0.000763	CcSEcCtD
Eprosartan—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000321	0.000761	CcSEcCtD
Eprosartan—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00032	0.000759	CcSEcCtD
Eprosartan—Rash—Azathioprine—systemic scleroderma	0.000319	0.000757	CcSEcCtD
Eprosartan—Dermatitis—Azathioprine—systemic scleroderma	0.000319	0.000756	CcSEcCtD
Eprosartan—Depression—Methotrexate—systemic scleroderma	0.000319	0.000756	CcSEcCtD
Eprosartan—Headache—Azathioprine—systemic scleroderma	0.000317	0.000752	CcSEcCtD
Eprosartan—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000317	0.000751	CcSEcCtD
Eprosartan—Dizziness—Leflunomide—systemic scleroderma	0.000316	0.00075	CcSEcCtD
Eprosartan—Renal failure—Methotrexate—systemic scleroderma	0.000315	0.000745	CcSEcCtD
Eprosartan—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000313	0.000742	CcSEcCtD
Eprosartan—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000312	0.00074	CcSEcCtD
Eprosartan—Conjunctivitis—Methotrexate—systemic scleroderma	0.000311	0.000737	CcSEcCtD
Eprosartan—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000308	0.00073	CcSEcCtD
Eprosartan—Pain—Mycophenolate mofetil—systemic scleroderma	0.000308	0.00073	CcSEcCtD
Eprosartan—Haematuria—Methotrexate—systemic scleroderma	0.000305	0.000723	CcSEcCtD
Eprosartan—Vomiting—Leflunomide—systemic scleroderma	0.000304	0.000721	CcSEcCtD
Eprosartan—Hypersensitivity—Lisinopril—systemic scleroderma	0.000303	0.000718	CcSEcCtD
Eprosartan—Dizziness—Mycophenolic acid—systemic scleroderma	0.000302	0.000715	CcSEcCtD
Eprosartan—Epistaxis—Methotrexate—systemic scleroderma	0.000302	0.000715	CcSEcCtD
Eprosartan—Rash—Leflunomide—systemic scleroderma	0.000302	0.000715	CcSEcCtD
Eprosartan—Dermatitis—Leflunomide—systemic scleroderma	0.000301	0.000714	CcSEcCtD
Eprosartan—Nausea—Azathioprine—systemic scleroderma	0.000301	0.000713	CcSEcCtD
Eprosartan—Headache—Leflunomide—systemic scleroderma	0.0003	0.00071	CcSEcCtD
Eprosartan—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000297	0.000703	CcSEcCtD
Eprosartan—Asthenia—Lisinopril—systemic scleroderma	0.000295	0.000699	CcSEcCtD
Eprosartan—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000295	0.000698	CcSEcCtD
Eprosartan—Pruritus—Lisinopril—systemic scleroderma	0.000291	0.000689	CcSEcCtD
Eprosartan—Vomiting—Mycophenolic acid—systemic scleroderma	0.00029	0.000688	CcSEcCtD
Eprosartan—Rash—Mycophenolic acid—systemic scleroderma	0.000288	0.000682	CcSEcCtD
Eprosartan—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000288	0.000681	CcSEcCtD
Eprosartan—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000286	0.000678	CcSEcCtD
Eprosartan—Headache—Mycophenolic acid—systemic scleroderma	0.000286	0.000678	CcSEcCtD
Eprosartan—Pharyngitis—Methotrexate—systemic scleroderma	0.000285	0.000676	CcSEcCtD
Eprosartan—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000285	0.000675	CcSEcCtD
Eprosartan—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000285	0.000675	CcSEcCtD
Eprosartan—Nausea—Leflunomide—systemic scleroderma	0.000284	0.000673	CcSEcCtD
Eprosartan—Diarrhoea—Lisinopril—systemic scleroderma	0.000281	0.000667	CcSEcCtD
Eprosartan—Ill-defined disorder—Prednisone—systemic scleroderma	0.000278	0.000658	CcSEcCtD
Eprosartan—Visual impairment—Methotrexate—systemic scleroderma	0.000277	0.000656	CcSEcCtD
Eprosartan—Angioedema—Prednisone—systemic scleroderma	0.000273	0.000648	CcSEcCtD
Eprosartan—Dizziness—Lisinopril—systemic scleroderma	0.000272	0.000644	CcSEcCtD
Eprosartan—Nausea—Mycophenolic acid—systemic scleroderma	0.000271	0.000642	CcSEcCtD
Eprosartan—Malaise—Prednisone—systemic scleroderma	0.00027	0.000639	CcSEcCtD
Eprosartan—Vertigo—Prednisone—systemic scleroderma	0.000269	0.000637	CcSEcCtD
Eprosartan—Syncope—Prednisone—systemic scleroderma	0.000268	0.000636	CcSEcCtD
Eprosartan—Tinnitus—Methotrexate—systemic scleroderma	0.000268	0.000635	CcSEcCtD
Eprosartan—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000265	0.000629	CcSEcCtD
Eprosartan—Loss of consciousness—Prednisone—systemic scleroderma	0.000263	0.000623	CcSEcCtD
Eprosartan—Vomiting—Lisinopril—systemic scleroderma	0.000261	0.000619	CcSEcCtD
Eprosartan—Rash—Lisinopril—systemic scleroderma	0.000259	0.000614	CcSEcCtD
Eprosartan—Dermatitis—Lisinopril—systemic scleroderma	0.000259	0.000614	CcSEcCtD
Eprosartan—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000258	0.000612	CcSEcCtD
Eprosartan—Chills—Methotrexate—systemic scleroderma	0.000258	0.000611	CcSEcCtD
Eprosartan—Headache—Lisinopril—systemic scleroderma	0.000258	0.00061	CcSEcCtD
Eprosartan—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000255	0.000604	CcSEcCtD
Eprosartan—Myalgia—Prednisone—systemic scleroderma	0.000255	0.000604	CcSEcCtD
Eprosartan—Arthralgia—Prednisone—systemic scleroderma	0.000255	0.000604	CcSEcCtD
Eprosartan—Anxiety—Prednisone—systemic scleroderma	0.000254	0.000601	CcSEcCtD
Eprosartan—Discomfort—Prednisone—systemic scleroderma	0.000252	0.000596	CcSEcCtD
Eprosartan—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000246	0.000584	CcSEcCtD
Eprosartan—Nausea—Lisinopril—systemic scleroderma	0.000244	0.000579	CcSEcCtD
Eprosartan—Back pain—Methotrexate—systemic scleroderma	0.000242	0.000573	CcSEcCtD
Eprosartan—Shock—Prednisone—systemic scleroderma	0.00024	0.000569	CcSEcCtD
Eprosartan—Tachycardia—Prednisone—systemic scleroderma	0.000238	0.000565	CcSEcCtD
Eprosartan—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000238	0.000564	CcSEcCtD
Eprosartan—Hyperhidrosis—Prednisone—systemic scleroderma	0.000236	0.000559	CcSEcCtD
Eprosartan—Anorexia—Prednisone—systemic scleroderma	0.000233	0.000552	CcSEcCtD
Eprosartan—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000232	0.00055	CcSEcCtD
Eprosartan—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000229	0.000543	CcSEcCtD
Eprosartan—Rash—Mycophenolate mofetil—systemic scleroderma	0.000227	0.000538	CcSEcCtD
Eprosartan—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000227	0.000538	CcSEcCtD
Eprosartan—Headache—Mycophenolate mofetil—systemic scleroderma	0.000226	0.000535	CcSEcCtD
Eprosartan—Malaise—Methotrexate—systemic scleroderma	0.000225	0.000534	CcSEcCtD
Eprosartan—Vertigo—Methotrexate—systemic scleroderma	0.000225	0.000532	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000222	0.000527	CcSEcCtD
Eprosartan—Insomnia—Prednisone—systemic scleroderma	0.000221	0.000523	CcSEcCtD
Eprosartan—Paraesthesia—Prednisone—systemic scleroderma	0.000219	0.00052	CcSEcCtD
Eprosartan—Cough—Methotrexate—systemic scleroderma	0.000218	0.000517	CcSEcCtD
Eprosartan—Dyspepsia—Prednisone—systemic scleroderma	0.000215	0.000509	CcSEcCtD
Eprosartan—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000214	0.000507	CcSEcCtD
Eprosartan—Chest pain—Methotrexate—systemic scleroderma	0.000213	0.000504	CcSEcCtD
Eprosartan—Arthralgia—Methotrexate—systemic scleroderma	0.000213	0.000504	CcSEcCtD
Eprosartan—Myalgia—Methotrexate—systemic scleroderma	0.000213	0.000504	CcSEcCtD
Eprosartan—Decreased appetite—Prednisone—systemic scleroderma	0.000212	0.000503	CcSEcCtD
Eprosartan—Fatigue—Prednisone—systemic scleroderma	0.000211	0.000499	CcSEcCtD
Eprosartan—Discomfort—Methotrexate—systemic scleroderma	0.00021	0.000498	CcSEcCtD
Eprosartan—Constipation—Prednisone—systemic scleroderma	0.000209	0.000495	CcSEcCtD
Eprosartan—Feeling abnormal—Prednisone—systemic scleroderma	0.000201	0.000477	CcSEcCtD
Eprosartan—Thrombocytopenia—Methotrexate—systemic scleroderma	0.0002	0.000473	CcSEcCtD
Eprosartan—Gastrointestinal pain—Prednisone—systemic scleroderma	0.0002	0.000473	CcSEcCtD
Eprosartan—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000197	0.000467	CcSEcCtD
Eprosartan—Anorexia—Methotrexate—systemic scleroderma	0.000195	0.000461	CcSEcCtD
Eprosartan—Urticaria—Prednisone—systemic scleroderma	0.000194	0.00046	CcSEcCtD
Eprosartan—Abdominal pain—Prednisone—systemic scleroderma	0.000193	0.000457	CcSEcCtD
Eprosartan—Body temperature increased—Prednisone—systemic scleroderma	0.000193	0.000457	CcSEcCtD
Eprosartan—Hypotension—Methotrexate—systemic scleroderma	0.000191	0.000452	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000186	0.000441	CcSEcCtD
Eprosartan—Insomnia—Methotrexate—systemic scleroderma	0.000185	0.000437	CcSEcCtD
Eprosartan—Paraesthesia—Methotrexate—systemic scleroderma	0.000183	0.000434	CcSEcCtD
Eprosartan—Dyspnoea—Methotrexate—systemic scleroderma	0.000182	0.000431	CcSEcCtD
Eprosartan—Somnolence—Methotrexate—systemic scleroderma	0.000181	0.00043	CcSEcCtD
Eprosartan—Hypersensitivity—Prednisone—systemic scleroderma	0.00018	0.000426	CcSEcCtD
Eprosartan—Dyspepsia—Methotrexate—systemic scleroderma	0.00018	0.000426	CcSEcCtD
Eprosartan—Decreased appetite—Methotrexate—systemic scleroderma	0.000177	0.00042	CcSEcCtD
Eprosartan—Fatigue—Methotrexate—systemic scleroderma	0.000176	0.000417	CcSEcCtD
Eprosartan—Asthenia—Prednisone—systemic scleroderma	0.000175	0.000415	CcSEcCtD
Eprosartan—Pain—Methotrexate—systemic scleroderma	0.000175	0.000414	CcSEcCtD
Eprosartan—Pruritus—Prednisone—systemic scleroderma	0.000173	0.000409	CcSEcCtD
Eprosartan—Feeling abnormal—Methotrexate—systemic scleroderma	0.000168	0.000398	CcSEcCtD
Eprosartan—Diarrhoea—Prednisone—systemic scleroderma	0.000167	0.000396	CcSEcCtD
Eprosartan—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000167	0.000395	CcSEcCtD
Eprosartan—Urticaria—Methotrexate—systemic scleroderma	0.000162	0.000384	CcSEcCtD
Eprosartan—Dizziness—Prednisone—systemic scleroderma	0.000161	0.000383	CcSEcCtD
Eprosartan—Abdominal pain—Methotrexate—systemic scleroderma	0.000161	0.000382	CcSEcCtD
Eprosartan—Body temperature increased—Methotrexate—systemic scleroderma	0.000161	0.000382	CcSEcCtD
Eprosartan—Vomiting—Prednisone—systemic scleroderma	0.000155	0.000368	CcSEcCtD
Eprosartan—Rash—Prednisone—systemic scleroderma	0.000154	0.000365	CcSEcCtD
Eprosartan—Dermatitis—Prednisone—systemic scleroderma	0.000154	0.000364	CcSEcCtD
Eprosartan—Headache—Prednisone—systemic scleroderma	0.000153	0.000362	CcSEcCtD
Eprosartan—Hypersensitivity—Methotrexate—systemic scleroderma	0.00015	0.000356	CcSEcCtD
Eprosartan—Asthenia—Methotrexate—systemic scleroderma	0.000146	0.000347	CcSEcCtD
Eprosartan—Nausea—Prednisone—systemic scleroderma	0.000145	0.000344	CcSEcCtD
Eprosartan—Pruritus—Methotrexate—systemic scleroderma	0.000144	0.000342	CcSEcCtD
Eprosartan—Diarrhoea—Methotrexate—systemic scleroderma	0.00014	0.000331	CcSEcCtD
Eprosartan—Dizziness—Methotrexate—systemic scleroderma	0.000135	0.00032	CcSEcCtD
Eprosartan—Vomiting—Methotrexate—systemic scleroderma	0.00013	0.000307	CcSEcCtD
Eprosartan—Rash—Methotrexate—systemic scleroderma	0.000129	0.000305	CcSEcCtD
Eprosartan—Dermatitis—Methotrexate—systemic scleroderma	0.000129	0.000305	CcSEcCtD
Eprosartan—Headache—Methotrexate—systemic scleroderma	0.000128	0.000303	CcSEcCtD
Eprosartan—Nausea—Methotrexate—systemic scleroderma	0.000121	0.000287	CcSEcCtD
